ClinicalTrials.Veeva

Menu

The Discovery of the Double Sphincter in Gallbladder

G

Guangzhou Medical University

Status and phase

Unknown
Phase 4

Conditions

Gallstone

Treatments

Drug: Tauroursodeoxycholic acid

Study type

Interventional

Funder types

Other

Identifiers

NCT01998451
GYGDWK-03

Details and patient eligibility

About

We found a new Double sphincter which located in the neck of gallbladder,we supposed it may be related to control pressure of bile duct.Its formation is related to genetic factors.

Full description

To contrast the recurrence rate of gallstones between patients with gallbladder double sphincter and patients with general gallbladder sphincter who underwent the treatment of cholecystolithiasis by minimally invasive cholecystolithotomy with gallbladder reservation. Method:Patients with gallbladder double sphincter and patients with general gallbladder sphincter who underwent the treatment of cholecystolithiasis by minimally invasive cholecystolithotomy with gallbladder reservation in The Affiliated Hospital of Guiyang Medical College from May 2012 to December 2015. We collect these patients' bile during surgery.Patients with gallbladder double sphincter as trial group, patients with general gallbladder sphincter as control group.the overall follow-up period is 3 years. Then the investigators statistically analyze improvement of cholecystolithiasis symptoms, thickness of gall bladder wall, the gallbladder function and the rate of the recurrence of cholesterol gallstone in 2 groups.we also analysis of the genetic differences from bile between two groups.

Enrollment

150 estimated patients

Sex

All

Ages

15 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • people with gallbladder double sphincter

Exclusion criteria

  • people without gallbladder double sphincter

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

150 participants in 2 patient groups

Double sphincter group
Experimental group
Description:
patients from double sphincter group all received Tauroursodeoxycholic acid after surgery for 6 months.
Treatment:
Drug: Tauroursodeoxycholic acid
general gallbladder sphincter group
Other group
Description:
patients from general gallbladder sphincter group all received Tauroursodeoxycholic acid after surgery for 6 months.
Treatment:
Drug: Tauroursodeoxycholic acid

Trial contacts and locations

1

Loading...

Central trial contact

Chengyi Sun, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems